South African experts comment on FDA approval of dabigatran inatrial fibrillation

Lignende værker

• FDA committee unanimously recommends approval of dabigatran etexilate for stroke prevention in atrial fibrillation
  af: J, Aalbers, et al.
  Udgivet: (2010)
• ARBs and risk of cancer: international and South African expert comment
  Udgivet: (2010)
• Thrombolysis risk prediction: applying the SITS-SICH and SEDAN scores in South African patients
  af: von Klemperer, A, et al.
  Udgivet: (2014)
• Smoking and vascular dysfunction in Africans and Caucasians from South Africa
  af: Zatu, Mandlenkosi C, et al.
  Udgivet: (2011)
• FDA's Center for Biologics Evaluation and Research comments on the Report of the expert panel.
  af: Quinnan, G V
  Udgivet: (1991)